Navigation Links
MedApps Receives Prestigious Frost & Sullivan Award
Date:2/6/2008

SCOTTSDALE, Ariz., Feb. 6 /PRNewswire/ -- MedApps announced today that it is the proud recipient of the 2008 Frost & Sullivan North American Technology Innovation Award in the field of Wireless Point of Care.

Frost & Sullivan's Technology Innovation Award is bestowed upon a company (or individual) that has carried out new research, which has resulted in innovation(s) that have or are expected to bring significant contributions to the industry in terms of adoption, change, and competitive posture. This award recognizes the quality and depth of a company's research and development program as well as the vision and risk-taking that enabled it to undertake such an endeavor.

"Frost & Sullivan does not accept nominations or submissions for their Awards," said Jeff Frigstad, Global Director of Frost & Sullivan's Best Practices Awards division. "The selection of this Award comes through in-depth interviews and primary market analysis conducted by our industry analyst team."

MedApps has been recognized for its unique technologies (Body Area Network and BluePAL(TM)) forming the backbone of its Telemedicine 2.0 concept. Telemedicine 2.0 as compared to the wired technology of Telemedicine 1.0 is a wireless technology, which is designed to help those patients who suffer from one or more chronic diseases such as diabetes, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), asthma or other diseases. This new technology can help healthcare professionals monitor and react to changes in a patient's medical condition as they occur. The company's dedication toward developing this novel real-time telemedicine technology platform employing individual techniques such as Body Area Network and BluePAL(TM) has attracted considerable industry interest as the nature of commercial remote glucose monitoring still remains adynamic.

"As a team, we are very proud of receiving this award," said Kent Dicks, President / CEO of MedApps. "To be recognized by Frost & Sullivan, a leading authority in industry / market trends, is extremely satisfying knowing that we are on the right track, with the right vision, at the right point in time."

About Frost & Sullivan

Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.awards.frost.com.

About MedApps

MedApps, headquartered in Scottsdale, Arizona, is a new and emerging leader in Mobile Wireless Health Monitoring -- designed to connect people with their healthcare providers, in a timely and cost effective manner. MedApps was named to the Fierce Health IT Top 10 Healthcare IT Innovators for 2007 (http://www.fiercehealthit.com/innovators/2007/medapps) and was nominated for the Governors Celebration of Innovation - Startup for 2007 (http://www.celebration-of-innovation.com/news.aspx).

http://www.medapps.net

Media Contact:

Randy Strength

MedApps, Inc.

(480) 686-5676

randy.strength@medapps.net


'/>"/>
SOURCE MedApps, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. IDM Pharma Receives Notification from NASDAQ Relating to Minimum Bid Price
2. Ludwig Institute for Cancer Research receives NHMRCs largest 2009 grant
3. Jacobs Receives Contract from Catholic Healthcare West to Assist Sequoia Hospital Expansion Program
4. Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
5. Regions Hospital Receives National Quality Awards
6. Laser Energetics Receives a $550,000 Order for a Dental Laser System
7. China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
8. Abbotts Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
9. Disabled Sacramento Woman, 110, Receives Power Wheelchair Donation from The SCOOTER Store
10. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
11. Siemens Receives FDA 510(K) Clearance for Next Generation Radiation Therapy Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
Breaking Medicine Technology: